← Leaderboards
Jr., Henry C Pitot
University Of Wisconsin Madison
$4,892,443
Attributed
$4,892,443
Total exposure
12
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $372.1K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$11,293,238 · 13
By mechanism
P01$7,230,311 · 3
R01$2,065,447 · 1
P30$1,981,911 · 7
M01$15,569 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- David R Andes$20,347,146
- Joan H Schiller$7,395,575
- Eric V Shusta$15,385,532
- Clive Niels Svendsen$19,591,596
- Laura L Kiessling$32,685,895
Others in their field
Top investigators on “Autoradiography”
- Steven H Liang · Emory University$25,785,853
- Joel Synes Perlmutter · Washington University$15,350,120
- Robert H Mach · Wake Forest University$12,427,124
- Brian D. Ross · University Of Michigan At Ann Arbor$10,225,810
- Hank F Kung · University Of Pennsylvania$9,991,131
- Donald Eugene Redmond · Yale University$8,488,041
Research focus
AutoradiographyChemical CarcinogenesisNeoplasm /Cancer GeneticsProceduresGrantComprehensive Cancer CenterTissue /Cell CultureIn Situ HybridizationLaboratory RatBiomedical FacilityLeadershipFreezingModificationNeoplastic ProcessEnsureMalignant NeoplasmsMonitorClinicAuthorityHematologic NeoplasmsAmendmentDiagnostic ServicesClinical Research ProtocolsMayo Clinic Cancer Center
Grant awards (45)
Protocol Review and Monitoring System$91,417
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$7,438
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$6,546
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$2,609
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$92,372
P30 · FY2017 · CA · contact PI
Protocol Review and Monitoring System$91,421
P30 · FY2016 · CA · contact PI
Protocol Review and Monitoring System$93,173
P30 · FY2015 · CA · contact PI
Protocol Review and Monitoring System$95,622
P30 · FY2014 · CA · contact PI
Experimental Pathology$150,295
P30 · FY2011 · CA · contact PI
Experimental Pathology$180,704
P30 · FY2010 · CA · contact PI
Experimental Pathology$171,542
P30 · FY2009 · CA · contact PI
Histechnology Core$94,962
P01 · FY2009 · CA · contact PI
Experimental Pathology$169,592
P30 · FY2008 · CA · contact PI
Histechnology Core$92,168
P01 · FY2008 · CA · contact PI
Experimental Pathology$180,028
P30 · FY2007 · CA · contact PI
Histotechnology Core$91,254
P01 · FY2007 · CA · contact PI
Instability of Tumor Promotion in Hepatocarcinogenesis$300,502
R01 · FY2006 · CA · contact PI
Histotechnology Core$71,616
P01 · FY2006 · CA · contact PI
Instability of Tumor Promotion in Hepatocarcinogenesis$307,733
R01 · FY2005 · CA
PHASE I TRIAL OF OSI-774 AND CPT-11 IN PATIENTS WITH ADVANCED SOLID TUMORS$1,185
M01 · FY2005 · RR
TRIAL OF ZOLEDRONIC ACID (ZOMETA) VERSUS ACID AND BMS-275291$711
M01 · FY2005 · RR
Instability of Tumor Promotion in Hepatocarcinogenesis$307,733
R01 · FY2004 · CA
Phase I Trial of OSI-774 /CPT-11 in Patients w /Solid Tu$12,746
M01 · FY2004 · RR
Trial of Zoledronic Acid (Zometa) vs Acid and BMS-275291$927
M01 · FY2004 · RR
Instability of Tumor Promotion in Hepatocarcinogenesis$307,733
R01 · FY2003 · CA
BIOCHEMISTRY AND GENETICS OF CHEMICAL CARCINOGENESIS$2,221,541
P01 · FY2002 · CA
Instability of Tumor Promotion in Hepatocarcinogenesis$307,733
R01 · FY2002 · CA
CORE--EXPERIMENTAL PATHOLOGY$0
P30 · FY2002 · CA
CORE--HISTOTECHNOLOGY LABORATORY$0
P01 · FY2002 · CA
CELL, MOLECULAR AND GENETIC CHARACTERIZATION OF PROGRESSION OF A HEPATOCARCINOGEN$0
P01 · FY2002 · CA
BIOCHEMISTRY AND GENETICS OF CHEMICAL CARCINOGENESIS$2,067,788
P01 · FY2001 · CA
INSTABILITY OF TUMOR PROMOTION IN HEPATOCARCINOGENESIS$270,913
R01 · FY2001 · CA
BIOCHEMISTRY AND GENETICS OF CHEMICAL CARCINOGENESIS$93,014
P01 · FY2001 · CA
CORE--HISTOTECHNOLOGY LABORATORY$0
P01 · FY2001 · CA
CELL, MOLECULAR AND GENETIC CHARACTERIZATION OF PROGRESSION OF A HEPATOCARCINOGEN$0
P01 · FY2001 · CA
CELL, MOLECULAR AND GENETIC CHARACTERIZATION OF PROGRESSION OF A HEPATOCARCINOGEN$0
P01 · FY2001 · CA
CORE--HISTOTECHNOLOGY LABORATORY$0
P01 · FY2001 · CA
CORE--EXPERIMENTAL PATHOLOGY$0
P30 · FY2001 · CA
BIOCHEMISTRY AND GENETICS OF CHEMICAL CARCINOGENESIS$2,018,452
P01 · FY2000 · CA
INSTABILITY OF TUMOR PROMOTION IN HEPATOCARCINOGENESIS$263,100
R01 · FY2000 · CA
CORE--HISTOTECHNOLOGY LABORATORY$239,758
P01 · FY2000 · CA
CELL, MOLECULAR AND GENETIC CHARACTERIZATION OF PROGRESSION OF A HEPATOCARCINOGEN$239,758
P01 · FY2000 · CA
CORE--SCIENTIFIC COMMUNICATIONS$216,384
P30 · FY2000 · CA
CORE--HISTOTECHNOLOGY LABORATORY$216,384
P30 · FY2000 · CA
CORE--MICROSCOPY FACILITY$216,384
P30 · FY2000 · CA